Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of S38093 versus placebo in mild to moderate Alzheimer's disease
2008-007670-37Phase 2Completed
- Sponsor
- Servier
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing S38093 with Placebo (2 arms). Primary endpoint: Safety outcomes. Started Mar 2009; status: completed.
02
Drugs
S-38093
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2008-007670-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007670-37.